egrifta sv - tesamorelin
(Tesamorelin)Theratechnologies Inc.
Usage: EGRIFTA SV reduces excess abdominal fat in HIV-infected adults with lipodystrophy. Not indicated for weight loss management; has a weight-neutral effect. Long-term cardiovascular safety has not been established.